Zobrazeno 1 - 10
of 41
pro vyhledávání: '"JM Ruiz Gonzalez"'
Autor:
S Guijarro Herrera, J Pastor Hurtado, CM Valencia Soto, JM Ruiz Gonzalez, Toscano Guzmán, E Román Márquez, S Cortes de Miguel, MV Villacañas Palomares
Publikováno v:
Eur J Hosp Pharm
Background In Spain, a therapeutic positioning report (TPR) for sacubitril valsartan indicates its use in adult patients for the treatment of symptomatic chronic heart failure and reduced ejection fraction (left ventricular ejection fraction (LVEF)
Publikováno v:
Eur J Hosp Pharm
Background Angiokeratomas are benign vascular skin lesions characterised by proliferation of dilated blood vessels in the upper dermis. Some variants have been described that can affect different regions of the body including face and genitals. They
Publikováno v:
European Journal of Hospital Pharmacy. 22:A5.1-A5
Background Spain accounts for the highest antibiotic use in Europe. Different studies have reported between 30 and 50% of antibiotic treatments are inappropriate in hospital. Purpose To assess the impact of pharmaceutical interventions in controlling
Publikováno v:
European Journal of Hospital Pharmacy. 22:A23.2-A23
Background Interventions made by clinical pharmacists have shown to reduce the frequency of drug-related problems. Purpose To describe all Pharmaceutical Interventions performed, assessing the type, medical units involved and the pharmacotherapeutic
Autor:
P Nieto Guindo, JM Ruiz Gonzalez, AF Verdejo Reche, H Mateo Carrasco, FD Fernández Ginés, E Martinez Velasco
Publikováno v:
European Journal of Hospital Pharmacy. 21:A171.1-A171
Background Pharmaceutical care might help optimise antibiotic use. However, assessing the influence of pharmacy interventions in the management of antimicrobials is not easy, and results from different studies reveal somewhat contradictory results. P
GRP-024 Antithrombotic Prophylaxis in Patients with Multiple Myeloma Being Treated with Lenalidomide
Autor:
JJ Fernández Ávila, M Giménez Ramos, JM Ruiz Gonzalez, FD Fernández Ginés, E Molina Cuadrado, P Nieto Guindo
Publikováno v:
European Journal of Hospital Pharmacy. 20:A9.2-A9
Background The diagnosis of multiple myeloma (MM) has been associated with a greater risk of thromboembolic events. At the same time, the treatment with lenalidomide, an immunomodulator authorised in 2007 by the EMA, causes a significant increase in
Publikováno v:
Clinical Respiratory Journal. Feb2018, Vol. 12 Issue 2, p425-432. 8p.
Autor:
Athlin, Simon1 (AUTHOR) simon.athlin@orebroll.se, Strålin, Kristoffer1,2 (AUTHOR)
Publikováno v:
Scandinavian Journal of Infectious Diseases. Jun2013, Vol. 45 Issue 6, p425-431. 7p.
Autor:
Fernandes, Rosa Anita, Perez-Andres, Martin, Blanco, Elena, Jara-Acevedo, Maria, Criado, Ignacio, Almeida, Julia, Botafogo, Vitor, Coutinho, Ines, Paiva, Artur, van Dongen, Jacques J. M., Orfao, Alberto, Faria, Emilia
Publikováno v:
Frontiers in Immunology; 11/8/2019, Vol. 10, p1-13, 13p
Autor:
Woodhead, M.1, Blasi, F.2, Ewig, S.3, Garau, J.4, Huchon, G.5, Ieven, M.6, Ortqvist, A.7, Schaberg, T.8, Torres, A.9, van der Heijden, G.10, Read, R.11, Verheij, T. J. M.12
Publikováno v:
Clinical Microbiology & Infection. Nov2011 Supplement, Vol. 17, pE1-E59. 59p.